GSK opens new €8m plant at Dungarvan site
New facility is only second of its kind in Ireland and will reduce carbon emissions by 33%
23 June 2017
Healthcare company GSK has announced the opening of an €8m investment project at its manufacturing site in Dungarvan. The facility was officially opened by site director Brian Fox.
The investment has been utilised to develop a new purpose-built biomass energy facility, which is expected to reduce the site’s carbon emissions by up to 33%. The facility uses locally sourced woodchips to create a carbon neutral fuel source for the site.
The development of the Dungarvan facility is part of GSK’s global sustainability strategy, which supports the company’s carbon neutral policy. This policy has set challenging carbon, water and waste reduction targets for all GSK manufacturing sites across the world. Dungarvan has responded with significant reductions in energy usage across its plant, delivered by highly efficient, world class engineering and energy management systems. The biomass energy facility also utilises a sustainable fuel supply as the wood chip it burns is made from waste wood by-product and the ash produced is used in fertiliser, which grow more trees.
GSK, which this year celebrates 35 years in Dungarvan, employs over 700 employees at two sites in the area.
“This investment from GSK is a significant vote of confidence in the Dungarvan facility, as well as in the capabilities of the town and people of Dungarvan to support such strategic developments,” said site director Brian Fox. “GSK is in Dungarvan 35 years this year, and this investment will underpin our existing investments here and our sizeable workforce.
“It will also significantly enhance Dungarvan’s role in GSK’s global business and today’s investment is a strong recognition of the strong technical and scientific capability we have here,” Fox said.